Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review

[1]  J Wang,et al.  A Meta-Analysis on the Diagnostic Performance of 18F-FDG and 11C-Methionine PET for Differentiating Brain Tumors , 2014, American Journal of Neuroradiology.

[2]  B. Ge,et al.  Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis , 2014, Acta radiologica.

[3]  L. Ceriani,et al.  Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis , 2014, Clinical chemistry and laboratory medicine.

[4]  K. Kairemo,et al.  Meta-analysis of 11C-choline and 18F-choline PET/CT for management of patients with prostate cancer , 2014, Nuclear medicine communications.

[5]  D. Volterrani,et al.  Multiagent targeting of neuroendocrine neoplasms , 2013, Clinical and Translational Imaging.

[6]  S. Larson,et al.  Tumor biology as a basis for molecular targeting in cancer , 2013, Clinical and Translational Imaging.

[7]  S. Ramin,et al.  Application of 11C‐acetate positron‐emission tomography (PET) imaging in prostate cancer: systematic review and meta‐analysis of the literature , 2013, BJU international.

[8]  S. Deng,et al.  Detection of glioma recurrence by 11C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis , 2013, Nuclear medicine communications.

[9]  L. Breimer,et al.  Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  L. Bachmann,et al.  The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. , 2013, European urology.

[11]  P. Muzzio,et al.  Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. , 2013, European urology.

[12]  D. Rubello,et al.  Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer: A Systematic Review and Meta-Analysis , 2013, Clinical nuclear medicine.

[13]  T. Nihashi,et al.  Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis , 2013, American Journal of Neuroradiology.

[14]  John O. Prior,et al.  Diagnostic accuracy of F-18-fluoroethyltyrosine PET and PET/CT in patients with brain tumor , 2013, Clinical and Translational Imaging.

[15]  Ji-gang Yang,et al.  Diagnostic role of 18F-dihydroxyphenylalanine positron emission tomography in patients with congenital hyperinsulinism: a meta-analysis , 2013, Nuclear medicine communications.

[16]  M. Marzola,et al.  Comparative studies of radiolabeled choline positron emission tomography, histology of primary tumor and other imaging modalities in prostate cancer: a systematic review and meta-analysis , 2013, Clinical and Translational Imaging.

[17]  U. Tateishi,et al.  Diagnostic accuracy of 18F-fluoride PET and PET/CT in patients with bone metastases: a systematic review and meta-analysis update , 2013, Clinical and Translational Imaging.

[18]  G. Treglia,et al.  Meta-analyses and systematic reviews on PET and PET/CT in oncology: the state of the art , 2013, Clinical and Translational Imaging.

[19]  O. Catalano,et al.  Whole-body PET/MRI in oncology: current status and clinical applications , 2013, Clinical and Translational Imaging.

[20]  F. Montravers,et al.  Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis , 2013, Clinical and Translational Imaging.

[21]  O. Ratib.  PET/MRI: a new era in multimodality molecular imaging , 2013, Clinical and Translational Imaging.

[22]  G. Treglia,et al.  Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis , 2013, Endocrine.

[23]  A. Poscia,et al.  Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis. , 2012, Academic radiology.

[24]  G. Treglia,et al.  Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis , 2012, Pediatric Radiology.

[25]  A. Alavi,et al.  The Value of Radiologic Interventions and 18F-DOPA PET in Diagnosing and Localizing Focal Congenital Hyperinsulinism: Systematic Review and Meta-Analysis , 2012, Molecular Imaging and Biology.

[26]  M. Picchio,et al.  The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review , 2012, Annals of Nuclear Medicine.

[27]  G. Treglia,et al.  Usefulness of 11C-Methionine Positron Emission Tomography in Differential Diagnosis between Recurrent Tumours and Radiation Necro-sis in Patients with Glioma: An Overview , 2012 .

[28]  P. Castaldi,et al.  Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  P. Castaldi,et al.  Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis , 2012, Endocrine.

[30]  John O. Prior,et al.  Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis , 2012, The Journal of Nuclear Medicine.

[31]  U. Tateishi,et al.  A meta-analysis of 18F-Fluoride positron emission tomography for assessment of metastatic bone tumor , 2010, Annals of nuclear medicine.

[32]  A. Del Sole,et al.  Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients. , 2014, European journal of internal medicine.